![Sernova Corp. on Twitter: "We are pleased to announce an exclusive global strategic partnership with @Evotec, which will enable us to advance a potential 'functional cure' for insulin-dependent #diabetes without supply constraints. Sernova Corp. on Twitter: "We are pleased to announce an exclusive global strategic partnership with @Evotec, which will enable us to advance a potential 'functional cure' for insulin-dependent #diabetes without supply constraints.](https://pbs.twimg.com/media/FS9NuiMXEAE6vl0.jpg)
Sernova Corp. on Twitter: "We are pleased to announce an exclusive global strategic partnership with @Evotec, which will enable us to advance a potential 'functional cure' for insulin-dependent #diabetes without supply constraints.
![Sernova taps Evotec's insulin-producing cells to fill its pouch implant for diabetes | Fierce Biotech Sernova taps Evotec's insulin-producing cells to fill its pouch implant for diabetes | Fierce Biotech](https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1621963401/Screen%20Shot%202020-06-27%20at%204.30.11%20PM.png/Screen%20Shot%202020-06-27%20at%204.30.11%20PM.png?VersionId=y6XmytPtaAmdS9_.cZm_zu6tInA0VYSL)
Sernova taps Evotec's insulin-producing cells to fill its pouch implant for diabetes | Fierce Biotech
![Sernova in clinical development for functional cure of Type 1 Insulin-dependent diabetes - BioTuesdays Sernova in clinical development for functional cure of Type 1 Insulin-dependent diabetes - BioTuesdays](https://biotuesdays.com/wp-content/uploads/2021/01/2021-01-04_Sernova-1-1024x572.jpg)
Sernova in clinical development for functional cure of Type 1 Insulin-dependent diabetes - BioTuesdays
![Sernova - Sernova is a regenerative medicine therapeutic technologies company creating long-term healthcare Sernova - Sernova is a regenerative medicine therapeutic technologies company creating long-term healthcare](https://www.sernova.com/home/CellPouch.jpg)
Sernova - Sernova is a regenerative medicine therapeutic technologies company creating long-term healthcare
![IRW-News: Sernova Corp. : Sernovas Hauptprüfer präsentiert weitere positive, vorläufige Sicherheits- und Wirksamkeitsdaten aus der laufenden klinischen Phase-I/II-Studie zur Cell Pouch bei Typ-1-Diabetes in den USA IRW-News: Sernova Corp. : Sernovas Hauptprüfer präsentiert weitere positive, vorläufige Sicherheits- und Wirksamkeitsdaten aus der laufenden klinischen Phase-I/II-Studie zur Cell Pouch bei Typ-1-Diabetes in den USA](https://media.boersennews.de/images/news/diabetes-777002_1280.690.jpg)
IRW-News: Sernova Corp. : Sernovas Hauptprüfer präsentiert weitere positive, vorläufige Sicherheits- und Wirksamkeitsdaten aus der laufenden klinischen Phase-I/II-Studie zur Cell Pouch bei Typ-1-Diabetes in den USA
![Sernova touts first-in-human results from insulin-secreting cell implant for diabetes | Fierce Biotech Sernova touts first-in-human results from insulin-secreting cell implant for diabetes | Fierce Biotech](https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1562164555/cells-570676_1280.jpg/cells-570676_1280.jpg?VersionId=EDCY4mr2fGT8O4LH8QeGGHhQpf7CTOCl)
Sernova touts first-in-human results from insulin-secreting cell implant for diabetes | Fierce Biotech
![Sernova Corp. on Twitter: "@SernovaCorp Confirms Enduring Levels of Fasting C-Peptide in Bloodstream of First Patient in its Phase I/II Clinical Trial for Type-1 Diabetes https://t.co/k9sxHpDcLM #diabetes #regenerativemedicine #T1D https://t.co ... Sernova Corp. on Twitter: "@SernovaCorp Confirms Enduring Levels of Fasting C-Peptide in Bloodstream of First Patient in its Phase I/II Clinical Trial for Type-1 Diabetes https://t.co/k9sxHpDcLM #diabetes #regenerativemedicine #T1D https://t.co ...](https://pbs.twimg.com/media/EHFqgzpXYAE8rhb.png)
Sernova Corp. on Twitter: "@SernovaCorp Confirms Enduring Levels of Fasting C-Peptide in Bloodstream of First Patient in its Phase I/II Clinical Trial for Type-1 Diabetes https://t.co/k9sxHpDcLM #diabetes #regenerativemedicine #T1D https://t.co ...
![Sernova in clinical development for functional cure of Type 1 Insulin-dependent diabetes - BioTuesdays Sernova in clinical development for functional cure of Type 1 Insulin-dependent diabetes - BioTuesdays](https://biotuesdays.com/wp-content/uploads/2021/01/2021-01-04_Sernova-delivery-1024x443.jpg)
Sernova in clinical development for functional cure of Type 1 Insulin-dependent diabetes - BioTuesdays
![Sernova Achieves Positive Efficacy Endpoint in Phase I/II Clinical Trial for Type 1 Diabetes | TechAlliance Sernova Achieves Positive Efficacy Endpoint in Phase I/II Clinical Trial for Type 1 Diabetes | TechAlliance](http://techalliance.ca/wp-content/uploads/2020/02/sernova-feb-2020.png)
Sernova Achieves Positive Efficacy Endpoint in Phase I/II Clinical Trial for Type 1 Diabetes | TechAlliance
![Illustration of the Sernova Cell Pouch™. A, Plugs in situ within the... | Download Scientific Diagram Illustration of the Sernova Cell Pouch™. A, Plugs in situ within the... | Download Scientific Diagram](https://www.researchgate.net/publication/309010262/figure/fig1/AS:416217190944778@1476245319903/Illustration-of-the-Sernova-Cell-Pouch-A-Plugs-in-situ-within-the-Cell-Pouch-B.png)
Illustration of the Sernova Cell Pouch™. A, Plugs in situ within the... | Download Scientific Diagram
![Sernova: Perfekter Partner für Diabetes-Programm von Evotec? - shareribs.com - Technology - IT und Kommunikation Sernova: Perfekter Partner für Diabetes-Programm von Evotec? - shareribs.com - Technology - IT und Kommunikation](https://www.shareribs.com/uploads/RTEmagicC_20200602-PSH-RM-Diabetes-Competitive-Landscape.jpg.jpg)
Sernova: Perfekter Partner für Diabetes-Programm von Evotec? - shareribs.com - Technology - IT und Kommunikation
![Sernova berichtet, dass den beiden ersten Patienten der zweiten Kohorte in der klinischen Phase-I/II-Studie zu Typ-1-Diabetes in den USA eine Cell Pouch implantiert wurde Sernova berichtet, dass den beiden ersten Patienten der zweiten Kohorte in der klinischen Phase-I/II-Studie zu Typ-1-Diabetes in den USA eine Cell Pouch implantiert wurde](https://www.finanznachrichten.de/chart-sernova-corp-aktie-intraday-tradegate.png)